Institute for Follicular Lymphoma Innovation
Investor profile
Government / public
Institute for Follicular Lymphoma Innovation has backed 1 European tech company across 1 funding round in 2022, joining rounds totalling €24M. Most active in Healthtech. Data as of Nov 2026.
Deals
1
distinct rounds
Companies
1
backed
Active span
2022
1 yr
Total round €
€24M
sum of rounds joined
Deals by year
distinct rounds / yearInstitute for Follicular Lymphoma Innovation — deals by year — interactive chart.
Data table
| Institute for Follicular Lymphoma Innovation — deals by year | |
|---|---|
| 2022 | 1 |
Top sectors
by dealsInstitute for Follicular Lymphoma Innovation — top sectors — interactive chart.
Data table
| Institute for Follicular Lymphoma Innovation — top sectors | |
|---|---|
| Healthtech | 1 |
Stages
by dealsInstitute for Follicular Lymphoma Innovation — stages — interactive chart.
Data table
| Institute for Follicular Lymphoma Innovation — stages | |
|---|---|
| Other | 1 |
Countries
by dealsInstitute for Follicular Lymphoma Innovation — countries — interactive chart.
Data table
| Institute for Follicular Lymphoma Innovation — countries | |
|---|---|
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Araris Biotech | Switzerland | 1 | €24M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Araris Biotech | Other | €24M | 2022-10 |